Clinical Trials

1 enrolled 6 charts

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02424851 2022-01-27

OPTIMAL

31 enrolled 13 charts

Multiple Myeloma, Renal Insufficiency, Chronic, Renal Insufficiency, Neoplasms, Plasma Cell

NCT01535924 2021-11-19

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

26 enrolled 13 charts

Hodgkin Disease, Recurrence

NCT01234766 2021-05-18

Fol-BRITe

39 enrolled 6 charts

Lymphoma, Follicular

NCT02059239 2021-02-21

Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma

34 enrolled 22 charts

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT02477215 2020-10-22

Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma

38 enrolled 18 charts

Multiple Myeloma

NCT01490723 2020-05-05

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

20 enrolled 9 charts

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00901927 2020-04-03

Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma

14 enrolled 10 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT01491841 2020-03-04

BRP

Phase 1 Completed

33 enrolled 13 charts

Lymphoma, Non-Hodgkin

NCT01438177 2020-02-24

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

11 enrolled 9 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01049945 2020-02-11

Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

70 enrolled 11 charts

Multiple Myeloma

NCT00899431 2020-01-27

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

39 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00974233 2019-12-02

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

34 enrolled 16 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00916058 2019-06-04

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

57 enrolled 19 charts

Multiple Myeloma

NCT01165112 2018-12-05

TREC

48 enrolled 9 charts

Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse

NCT01133158 2018-11-01

R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

61 enrolled 8 charts

Lymphoma, Non-Hodgkin

NCT00867503 2018-07-24

Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer

10 enrolled 12 charts

Gynecologic

Ovarian Neoplasms

NCT01484626 2018-07-10

BVRD

Phase 1/2 Terminated

3 enrolled 4 charts

Multiple Myeloma

NCT02420210 2018-06-06

Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma

2 enrolled 7 charts

Lymphoma, Large B-Cell, Diffuse

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

11 enrolled 16 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01315873 2018-02-07

Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma

24 enrolled 3 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01626352 2017-11-22

Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy

22 enrolled 14 charts

Lymphoma, Large B-Cell, Diffuse

NCT00856830 2017-07-17

Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer

30 enrolled 12 charts

Thoracic

Small Cell Lung Carcinoma

NCT00823797 2017-07-07

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

45 enrolled 11 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma, Gliosarcoma

NCT01110135 2017-05-24

Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma

DermatologicLymphoidOther hematologic neoplasmPlasma cell

43 enrolled 5 charts

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT01234467 2017-05-24

Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma

23 enrolled 16 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT01056276 2017-05-03

Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

59 enrolled 9 charts

Multiple Myeloma

NCT00705250 2017-03-03

Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma

36 enrolled 5 charts

Hodgkin Disease, Lymphoma

NCT01010568 2015-12-15

Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)

10 enrolled 8 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00547534 2015-08-06

BVR

31 enrolled 9 charts

Lymphoma, Non-Hodgkin, Recurrence

NCT00426855 2015-04-03

Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

12 enrolled 6 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT00984542 2014-03-12

Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer